Forefront Analytics, LLC Provention Bio, Inc. Transaction History

Forefront Analytics, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.62 $22,054 - $36,136	-6,430 Reduced 30.01%	14,997 $68,000
Q2 2022 Aug 10, 2022	SELL	$3.65 - $7.3 $4,288 - $8,577	-1,175 Reduced 5.2%	21,427 $84,000
Q1 2022 May 09, 2022	BUY	$3.4 - $7.88 $3,060 - $7,092	900 Added 4.15%	22,602 $166,000
Q4 2021 Feb 11, 2022	BUY	$5.59 - $7.39 $3,354 - $4,434	600 Added 2.84%	21,702 $123,000
Q3 2021 Nov 15, 2021	BUY	$5.66 - $8.33 $119,437 - $175,779	21,102 New	21,102 $135,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

Stay updated on Forefront Analytics, LLC with notifications on news.